EI- Nile Co. for Pharmaceuticals and Chemical Industries (EGX:NIPH)

EGX:NIPH Balance Sheet

Financials in millions EGP. Fiscal year is July - June.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	21.2	21.36	34.35	21.44	53.57	109.61
Cash & Short-Term Investments	21.2	21.36	34.35	21.44	53.57	109.61
Cash Growth	154.99%	-37.82%	60.25%	-59.99%	-51.13%	24.47%
Accounts Receivable	941.08	277.96	87.82	164.93	99.54	109.38
Other Receivables	5.59	151.59	108	49.12	37.56	36.87
Receivables	1,115	614.5	351.75	420.67	304.23	227.32
Inventory	447.11	524.8	446.98	409.76	240.04	258.94
Prepaid Expenses	-	-	-	0.16	0.21	-
Other Current Assets	110.08	12.78	16.61	17.92	9.09	8.48
Total Current Assets	1,694	1,173	849.69	869.96	607.15	604.35
Property, Plant & Equipment	1,348	1,139	615.15	159.98	153.88	107.44
Long-Term Investments	13.22	8.35	8.35	8.35	8.35	8.35
Other Long-Term Assets	0	-	-	-	-	-
Total Assets	3,055	2,321	1,473	1,038	769.38	720.14

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Accounts Payable	112.73	124.9	157.11	164.08	135.21	174.99
Accrued Expenses	139.51	82.37	70.43	72.72	62.35	55.79
Short-Term Debt	931.51	639.29	241.78	154.38	79.78	43.39
Other Current Liabilities	319.53	355.63	196.55	106.7	57.34	70.86
Total Current Liabilities	1,503	1,202	665.87	497.88	334.68	345.03
Long-Term Debt	422.11	349.43	333.5	58.12	-	-
Long-Term Deferred Tax Liabilities	25.79	25.79	4.97	3.81	3.83	3.79
Total Liabilities	1,951	1,577	1,004	559.81	338.52	348.82

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Common Stock	500	300	101.25	101.25	101.25	101.25
Retained Earnings	578.29	422.87	347.2	357.13	310.16	250.61
Comprehensive Income & Other	25.27	20.41	20.41	20.11	19.46	19.46
Shareholders' Equity	1,104	743.29	468.86	478.48	430.87	371.32
Total Liabilities & Equity	3,055	2,321	1,473	1,038	769.38	720.14

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Total Debt	1,354	988.73	575.28	212.49	79.78	43.39
Net Cash (Debt)	-1,332	-967.37	-540.93	-191.06	-26.21	66.22
Net Cash Growth	-	-	-	-	-	49.87%
Net Cash Per Share	-26.65	-32.25	-53.42	-18.87	-2.59	6.54
Filing Date Shares Outstanding	50	30	10.13	10.13	10.13	10.13
Total Common Shares Outstanding	50	30	10.13	10.13	10.13	10.13
Working Capital	190.52	-28.76	183.82	372.08	272.47	259.32
Book Value Per Share	22.07	24.78	46.31	47.26	42.55	36.67
Tangible Book Value	1,104	743.29	468.86	478.48	430.87	371.32
Tangible Book Value Per Share	22.07	24.78	46.31	47.26	42.55	36.67
Land	0.55	0.55	0.55	0.55	0.55	0.55
Buildings	548.76	555.82	142.34	139.56	139.56	139.56
Machinery	778.58	594.57	266.77	263.52	259.33	250.68
Construction In Progress	420.74	325.89	535.67	79.45	67.57	17.17

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 5, 2026

Data Sources Report a data error